Form 4 for HIT Health In Tech, Inc.
Accepted 2026-09-16 17:21:06 ET · period of report 2026-09-15 · accession 0001213900-26-100592 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 17:21 | 2026-09-15 | HIT | Qian LinLin | CEO, Dir, 10% | F - Tax | $0.89 | -33.7K | 8.96M | -0.4% | -$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-15 | F | D | 33,725 | $0.89 | 8,964,667 | D | — | — | (F1) Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4. (F2) Includes 887,062 restricted shares of Class A Common Stock and 8,077,605 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock. |